Adeno-associated viral vector serotype 9-based gene replacement therapy for SURF1-related Leigh syndrome
SURF1 (surfeit locus protein 1)-related Leigh syndrome is an early-onset neurodegenerative disorder, characterized by reduction in complex IV activity, resulting in disrupted mitochondrial function. Currently, there are no treatment options available. To test our hypothesis that adeno-associated vir...
Main Authors: | Qinglan Ling, Matthew Rioux, Yuhui Hu, MinJae Lee, Steven J. Gray |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050121001364 |
Similar Items
-
Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients
by: Danis Daniel, et al.
Published: (2018-04-01) -
Supraspinal gene transfer by intrathecal adeno-associated virus serotype 5
by: Daniel J. Schuster, et al.
Published: (2014-08-01) -
A role for adeno-associated viral vectors in gene therapy
by: Renata dos Santos Coura, et al.
Published: (2008-01-01) -
Preclinical Assessment of Immune Responses to AAV (adeno-associated virus) Vectors
by: Etiena eBasner-Tschakarjan, et al.
Published: (2014-02-01) -
Recombinant Adeno-Associated Virus Serotype 6 (rAAV6) Potently and Preferentially Transduces Rat Astrocytes in vitro and in vivo
by: Alexandra L. Schober, et al.
Published: (2016-11-01)